Omokso-CV 625 Tablet
Marketer
Onechem Pharmaceuticals
Salt Composition
Amoxycillin (500mg) + Clavulanic Acid (125mg)
Overview Omokso-CV 625 Tablet
BactiComb 625mg tablets are a bacterial infection fighter. They combat infections in the lungs (like pneumonia), ears, sinuses, urinary tract, skin, and soft tissues. They are ineffective against viral illnesses such as the common cold. To minimize stomach discomfort, take BactiComb 625mg with food. Follow your doctor's prescribed schedule, taking the medication at evenly spaced intervals for consistent efficacy. Dosage varies depending on the infection; always complete the full course as directed, even if symptoms improve. Premature discontinuation may lead to infection recurrence or worsening. Common side effects include nausea, diarrhea, vomiting, oral or genital yeast infections, rashes, and vaginal infections. While usually mild, report persistent or bothersome side effects to your physician. Inform your doctor of any antibiotic allergies, kidney or liver issues, and all other medications you are currently using, as interactions are possible. Generally safe during pregnancy and breastfeeding under medical supervision.
Primary Ingredients of Omokso-CV 625 Tablet
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Omokso-CV 625 Tablet
Combating Bacterial Infections
Major Benefits of Omokso-CV 625 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Omokso-CV 625 Tablets should be administered with a meal.
Common Side effects of Omokso-CV 625 Tablet:
- Vaginal inflammation
- Mucocutaneous candidiasis
- Vomiting
- Nausea
- Diarrhea
- Skin rash
- Red spots or bumps
- Fungal infection
How to use Omokso-CV 625 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Omokso-CV 625 Tablets should be administered with a meal.
How Omokso-CV 625 Tablet works:
Omokso-CV 625 tablets contain amoxicillin, a bacterial growth inhibitor, and clavulanate potassium, a beta-lactamase inhibitor. Amoxicillin disrupts bacterial cell wall synthesis, hindering their ability to survive. Clavulanate potassium counters bacterial resistance mechanisms, thereby improving amoxicillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Omokso-CV 625 Tablet use alongside alcohol consumption presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnant individuals can typically use Omokso-CV 625 Tablet without safety concerns. Animal research indicates minimal or absent negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Omokso-CV 625 tablets are compatible. Research in humans indicates negligible transfer of the medication into breast milk, posing no discernible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Omokso-CV 625 Tablet side effects, including allergic reactions, dizziness, or seizures.
KidneyCAUTION
Patients with kidney impairment should use Omokso-CV 625 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. This medication is contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Omokso-CV 625 Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Routine liver function assessments are recommended during treatment.
What if you forget to take Omokso-CV 625 Tablet :
Should you forget a dose of Omokso-CV 625 Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Omokso-CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |



